CCR7 and malignant colon neoplasm: In the human colorectal carcinoma cell line, SW480, CCR7 knockdown using shRNA led to reduced MMP-9 levels that, when tested in a xenograft mouse model, lowered colon cancer metastasis and increased animal survival when compared to CCR7-expressing tumor cells [119].